CCL2 and systemic sclerosis: A significant increase was observed in sICAM-1, CCL2, CXCL8, and IL-13 along a disease spectrum gradient from UCTD-risk-SSc to limited cutaneous SSc (lcSSc) to diffuse cutaneous SSc (dcSSc).